EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study

Clinical trial NCT07281105 · COMPLETED

Trial details

NCT number: NCT07281105
Sponsor: Evergreen Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuropsychiatric Systemic Lupus Erythematosus Systemic Lupus Erythematosus (SLE)Cognitive Impairment

Start date: 2018-08-23
Primary completion: 2025-08-12
Enrollment: 131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.